Zobrazeno 1 - 10
of 146
pro vyhledávání: '"J.F. Blicklé"'
Publikováno v:
Diabetes & Metabolism. 41:A7-A8
Introduction Peu de donnees existent sur la prise en charge des patients diabetiques de type 2 (DT2) ≥ 75 ans, dont un grand nombre presente une alteration renale. Cette etude examine la prise en charge therapeutique en France en 2012, de cette pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d763b5427472e766d568d16eef375e9
https://doi.org/10.1016/s1262-3636(15)30025-2
https://doi.org/10.1016/s1262-3636(15)30025-2
Autor:
J.W.F. Elte, J.F. Blicklé
Publikováno v:
European Journal of Internal Medicine.
Thiazolidinediones (TZD), or glitazones, represent a new generation of antidiabetic drugs that have recently been introduced in Europe. They improve insulin resistance, one of the key anomalies involved in the pathogenesis of type 2 diabetes mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c09bbdd2bd416551a68ad4707925f1a9
https://doi.org/10.1016/j.ejim.2011.08.002
https://doi.org/10.1016/j.ejim.2011.08.002
Autor:
J.W.F. Elte, J.F. Blicklé
Publikováno v:
European Journal of Internal Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b265250eef2f4dbb3a15f5611267841e
https://doi.org/10.1016/j.ejim.2011.08.007
https://doi.org/10.1016/j.ejim.2011.08.007
Autor:
J.F. Blicklé, J.M. Brogard
Publikováno v:
La Revue de Médecine Interne. 13:S285-S288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6a798ae5bc6e7f4f5d20fe54739b02d
https://doi.org/10.1016/s0248-8663(05)80882-3
https://doi.org/10.1016/s0248-8663(05)80882-3
Autor:
J.M. Brogard, J.F. Blicklé
Publikováno v:
La Revue de Médecine Interne. 20:563-565
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f6fcd9d937d10da1c4278642c87c47a
https://doi.org/10.1016/s0248-8663(99)80104-0
https://doi.org/10.1016/s0248-8663(99)80104-0
Publikováno v:
Diabetesmetabolism. 33
Renal impairment is frequent in aged diabetic patients, notably with type 2 diabetes. It results from a multifactorial pathogeny, particularly the combined actions of hyperglycaemia, arterial hypertension and ageing. Diabetic nephropathy (DN) is asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb6c72b1aa2b567b1ce1b759cba3323
https://pubmed.ncbi.nlm.nih.gov/17702098
https://pubmed.ncbi.nlm.nih.gov/17702098
Autor:
J.F. Blicklé, J.W.F. Elte
Publikováno v:
European journal of internal medicine. 18(1)
Thiazolidinediones (TZD), or glitazones, represent a new generation of antidiabetic drugs that have recently been introduced in Europe. They improve insulin resistance, one of the key anomalies involved in the pathogenesis of type 2 diabetes mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7802ec562ad7df169f1b3c0c65497713
https://pubmed.ncbi.nlm.nih.gov/17223037
https://pubmed.ncbi.nlm.nih.gov/17223037
Autor:
J.F. Blicklé
Publikováno v:
Diabetesmetabolism.
Summary Hypertension is a major vascular risk factor in the elderly diabetic. The benefit of proper management is well recognized, even if treatment has no influence on overall mortality or might even tend to increase it in very elderly subjects. Glo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113ac3bfc42e9256e2ed0851bb98d907
https://pubmed.ncbi.nlm.nih.gov/16415770
https://pubmed.ncbi.nlm.nih.gov/16415770
Publikováno v:
Annales d'Endocrinologie. 74:388-389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78295ef61495361e1f5e3d31b15c8b3c
https://doi.org/10.1016/j.ando.2013.07.524
https://doi.org/10.1016/j.ando.2013.07.524
Publikováno v:
Néphrologie & Thérapeutique. 9:320
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99619011f5b112c426a17e2ac876a401
https://doi.org/10.1016/j.nephro.2013.07.006
https://doi.org/10.1016/j.nephro.2013.07.006